InvestmentMay 28, 2026, 04:00 PM
Outlook Therapeutics Raises $5.0M in Direct Offering
AI Summary
Outlook Therapeutics, Inc. announced a definitive agreement for a registered direct offering to its largest stockholder, GMS Ventures and Investments. The company will sell 8,539,709 shares of common stock at $0.5855 per share, expecting to raise $5.0 million in gross proceeds for working capital and general corporate purposes. Additionally, the company will amend outstanding common stock warrants for 15,488,570 shares, reducing their exercise price to $0.5855 per share from a previous weighted average of $1.78.
Key Highlights
- Outlook Therapeutics sold 8,539,709 shares of common stock in a registered direct offering.
- The purchase price per share was $0.5855.
- The offering is expected to generate $5.0 million in gross proceeds.
- Net proceeds will be used for working capital and general corporate purposes.
- The company agreed to amend warrants for 15,488,570 shares, reducing the exercise price to $0.5855 per share.
- The amended warrants were previously issued in January and May 2025 with a weighted average exercise price of $1.78 per share.
Price Impact
More from OTLK